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Background: Ectopic pregnancy (EP) is the leading cause of maternal death during the first trimester of pregnancy.
A better understanding of EP risk can help prevent its occurrence. We carried out a multi-center, large-sample,
case-control study to evaluate the risk factors for EP in Shanghai, China.
Methods: Women who were diagnosed with EP (n = 2411) and women with intrauterine pregnancies (n = 2416)
were recruited from five hospitals in Shanghai, China. Information regarding the sociodemographic characteristics;
reproductive, gynecological and surgical history; and previous and current use of contraceptives was collected from
all participants. Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated and adjusted for potential
confounding factors via multivariate logistic regression analysis.
Results: The study revealed that the risk of EP was associated with the traditional risk factors including previous EP
(Adjusted odds ratio [AOR] = 2.72, 95 % CI: 1.83–4.05), previous Chlamydia trachomatis infection (Adjusted OR = 3.18,
95 % CI: 2.64, 3.84), previous infertility (AOR = 2.18, 95 % CI: 1.66–2.88), previous adnexal surgery (AOR = 2.09, 95 %
CI: 1.49–2.93), previous appendectomy (AOR = 1.64, 95 % CI: 1.13–2.37), and previous use of intrauterine devices
(IUDs) (AOR = 1.72, 95 % CI: 1.39–2.13). Additionally, EP risk was increased following the failure of most
contraceptives used in the current cycle including IUDs (AOR = 16.43, 95 % CI: 10.42–25.89), oral contraceptive pills
(AOR = 3.02, 95 % CI: 1.16–7.86), levonorgestrel emergency contraception (AOR = 4.75, 95 % CI: 3.79–5.96), and
female sterilization (AOR = 4 .73, 95 % CI: 1.04–21.52). Stratified analysis showed that in vitro fertilization and embryo
transfer (IVF-ET) was the main risk factor for EP in women with tubal infertility (AOR = 8.99, 95 % CI: 1.98–40.84),
although IVF-ET showed no association with EP in women with non-tubal infertility (AOR = 2.52, 95 % CI: 0.14–44.67).
Conclusion: In addition to the traditional risk factors, IVF-ET and current IUD use play dominant roles in the
occurrence of EP. Attention should be given to women with tubal infertility who have undergone IVE-ET treatment.Background
Ectopic pregnancy (EP) is the leading cause of maternal
death during the first trimester of pregnancy, accounting
for approximately 10 % of all pregnancy-related deaths
[1]. It remains to be a condition presenting as a serious
health problem for women of childbearing age [2]. It has
been shown to reduce subsequent fertility and increase
the chances of subsequent EP [3]. Over recent decades,
there has been a rise in the incidence of EP [4].* Correspondence: zhangjian_ipmch@sjtu.edu.cn; qjchildren736@qq.com
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article, unless otherwise stated.There is extensive literature regarding the potential
risk factors for EP. The identified risk factors for EP
include age, previous EP, previous pelvic surgery, use of
intrauterine devices (IUDs), female sterilization, history
of pelvic inflammatory disease, history of infertility and
smoking at the time of conception [5–12]. The increased
awareness and knowledge on the risk factors for EP
could enable an early and accurate diagnosis of the
disease, resulting in a reduced need for surgery and
fewer complications.
However, the study designs of previous researches
focused on women not using contraception at the time
of conception to explore the risk factors for EP com-
prehensively, which failed to evaluate the associationdistributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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of conception and might make the results in an overall
ambiguity [7], because fertility intention might have a
great impact on pregnancy outcome when study the risk
factors for EP [13]. Furthermore, with the increased
incidence of EP, and variance in population structure
and regional differences, the risk factors of EP may have
changed. Additionally, due to the increased incidence
in infertility, currently approaches such as assisted
reproduction technology (ART) are more widely used;
therefore, their role and strength in the incidence of
EP should be re-evaluated [14, 15]. Different from the
previous study which investigated the risk factors for
EP in women with planned pregnancy only in one hospital
in Shanghai [16], the present was designed to conduct
in five hospitals covering the population across urban
and rural areas of Shanghai with a relatively good
representation of the population, in order to compre-
hensively evaluate all the risk factors for EP among
the general population, rather than those with planned
pregnancy.
Methods
Study design and participants
This case–control study was conducted at five medical
hospitals in Shanghai (two general hospitals and three
maternity hospitals). The study protocol was approved
by the Institutional Review Board of all the hospitals
(International Peace Maternity and Child Health Hos-
pital, Shanghai First People’s Hospital, Songjiang Central
Hospital, Songjiang Maternity and Child Health Hos-
pital, and Minhang Central Hospital). Written informed
consents were obtained from all the study participants
before they were interviewed.
From March 2011 and April 2013, women who had
been diagnosed with EPs in the inpatient gynecology
department of each hospital were interviewed as poten-
tial candidates for the case group (EP group). Women
with intrauterine pregnancy (IUP) at the prenatal and
family planning clinics of the same hospitals matched
for age (±5 years), marital status and gestational age
(±7 days) at a ratio of 1:1 were included in the study as
controls. The inclusion criteria of the study subjects
were as described in our previous study [17].
Data collection and variable specification
The definitions of previous and current use of contra-
ceptive methods have been described in our previous
study [17].
All participants were interviewed via a questionnaire
according to a standard protocol to obtain informa-
tion on sociodemographic characteristics (age, marital
status, education, birthplace, personal annual income,
smoking and institutions); reproductive, gynecologicaland surgical history (including number of previous abor-
tions, parity, history of previous EP, previous infertility,
categories of infertility, ARTs applied in the current cycle
of conception, previous Cesarean section, previous ad-
nexal surgery, specific adnexal surgery, previous ap-
pendectomy); previous use of contraceptives (including
levonorgestrel emergency contraception [LNG-EC]; IUDs;
oral contraceptive pills [OCPs]; and other methods such
as condoms, withdrawal method and calendar rhythm
method), and current use of contraceptives (IUDs; OCPs;
LNG-EC; female sterilization; and other methods such
as condoms, withdrawal method and calendar rhythm
method).
Serum Chlamydia trachomatis (CT) IgG antibodies
were detected using enzyme-linked immunosorbent assay
(ELISA; Beijing Biosynthesis Biotechnology, China) after
collecting 5-mL blood samples from each participant.Statistical analysis
We examined the frequency distribution of each variable
according to the case and control groups. Univariate
logistic regression analysis was used to estimate the
crude odds ratios (ORs) of each variable and their 95 %
confidence intervals (CIs). The variables associated with
EP by univariate analysis were included as candidates in
the multivariable logistic regression analysis by stepwise
selection with a SLENTRY level of 0.1 and SLSTAY level
of 0.1.
When we explored the association between the risk of
EP and ART, history of infertility was a major confound-
ing factor. Thus, the study participants with history of
infertility were divided into two strata, women with tubal
infertility and those with non-tubal infertility. The asso-
ciation between risk of EP and each ART were analyzed
in both strata. ORs and their 95 % CIs were calculated
and adjusted for other potential confounding factors,
including age (less than 20, 20–24, 25–30, 30–34, 35–39,
or greater than 40 years of age), medical hospitals (1, 2, 3,
4 or 5), educational level (primary school or less, middle
school, high school or college or higher degree), occupa-
tion (employed, self-employed or unemployed), previous
EP (no or yes), serum CT IgG test (negative or positive),
previous adnexal surgery (no or yes), previous appen-
dectomy (no or yes), previous use of IUDs (no or yes),
previous use of other contraceptive methods (no or yes),
and current use of contraceptive methods (not used,
OCPs, LNG-EC, IUDs, female sterilization or other
contraceptive methods).
All statistical analyses were performed using SAS
software, version 8.2 (SAS Institute, Inc., Cary, NC).
All p values were calculated using two-sided tests.
Differences between values were considered statisti-
cally significant at a p value of less than 0.05.
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From the study subjects, 148 EP and 118 IUP patients
either refused to participate in the interview or provided
incomplete information in the questionnaire survey; these
women were excluded from the study. Finally, 2411 EP
patients and 2416 IUP controls were included in this
study, and the response rate was 94.78 % (Fig. 1).
Univariate analysis
Table 1 presents the distribution of sociodemographic
characteristics between both the groups. EP patients
were more likely to be born out of Shanghai (p < 10−3),
have lower education attainment (p < 10−3), and be
self-employed/unemployed (p < 10−3). However, smok-
ing showed no relevance with EP (occasional smoker:
OR = 1.10, 95 % CI: 0.77–1.59; regular smoker: OR =
1.47, 95 % CI: 0.95–2.28; p = 0.41). Due to the match-
ing criteria of cases and controls in each hospital, there
showed no significant difference in age (p = 0.16), marital
status (p = 0.56) and institutions (p = 1.00) between the
two groups.
Table 2 revealed the results of the analyses of crude
association between the risk of EP and history of
reproduction, gynecology and surgery. The occurrence
of EP were showed to have a crude association with
some factors including parity (once: OR = 1.14, 95 %
CI: 1.02–1.30; more than twice: OR = 1.58, 95 % CI:
1.27–1.96), previous EP (OR = 6.67, 95 % CI: 5.04–
9.11), previous CT infection (OR = 3.83, 95 % CI:
3.27–4.48), history of infertility (OR = 4.42, 95 % CI:
3.53–5.53), in vitro fertilization and embryo transfer
(IVF-ET; OR = 5.01, 95 % CI: 1.53–16.44), previous
adnexal surgeries (OR = 5.42, 95 % CI: 4.29–6.84), and
previous appendectomy (OR = 1.67, 95 % CI: 1.21–2.31).
In terms of the contraceptive experience (Table 3), pre-
vious IUD use was also associated with a higher risk of EPFig. 1 Recruitment profile of the case–control studywith an OR of 1.48 (95 % CI: 1.25–1.74), whereas previous
use of other methods including condom, rhythm method
and withdrawal method was associated with a lower risk
(OR = 0.39, 95 % CI: 0.34–0.45). Furthermore, a crude
association was found between current use of most con-
traceptives and risk of EP (OCPs: OR = 2.71, 95 % CI:
1.11–6.61; LNG-EC: OR = 2.79, 95 % CI: 2.27–3.43; IUDs:
OR = 11.41, 95 % CI: 7.45–17.48; female sterilization:
OR = 12.45, 95 % CI: 2.91–53.18).Multivariate analysis
Table 4 shows the results of the multivariate analysis be-
tween the risk of EP and candidate risk factors. Poor edu-
cation and occupation were found to be independently
associated with the risk of EP. The results revealed that
women with previous EP (adjusted OR [AOR] = 2.72,
95 % CI: 1.83–4.05), previous CT infection (AOR = 3.18,
95 % CI: 2.64–3.84), a history of infertility (AOR = 2.18,
95 % CI: 1.66–2.88), previous adnexal surgery (AOR =
2.09, 95 % CI: 1.49–2.93), and previous appendectomy
(AOR = 1.64, 95 % CI: 1.13–2.37) were at a greater risk of
having an EP. With regards to contraception, previous
IUD use was found to slightly increase the risk of EP
(AOR = 1.72, 95 % CI: 1.39–2.13), while previous use of
other contraceptive methods including condom, rhythm
method and withdrawal method were shown to protect
women from the incidence of EP (AOR = 0.56, 95 % CI:
0.47–0.66). In addition, current use of most contracep-
tives was significantly correlated with the incidence of EP
following contraceptive failure, and the risk varied across
the different contraceptive methods (OCPs: AOR = 3.02,
95 % CI: 1.16–7.86; LNG-EC: AOR = 4.75, 95 % CI: 3.79–
5.96; IUDs: AOR = 16.43, 95 % CI: 10.42–25.89; female
sterilization: AOR = 4.73, 95 % CI: 1.04–21.52). Notably,
among women with a history of infertility, those who
resorted to IVF-ET in the current cycle of conception
showed a higher risk of EP (AOR = 9.28, 95 % CI: 2.14–
40.38) than those who got spontaneously pregnant, while
the use of Chinese herbal medicine and other ART
approaches was not associated with the risk of EP
(Chinese herbal medicine: OR = 0.80, 95 % CI: 0.41–1.56;
other ARTs: OR = 0.8, 95 % CI: 0.34–1.88).
Table 5 presents a stratified analysis of the association
between EP risk and the ARTs applied in the current
conception cycle, according to the different categories of
infertility. In women with tubal infertility, IVF-ET was
shown to significantly increase the risk of EP (AOR =
8.99, 95 % CI: 1.98–40.84). However, there were no sig-
nificant associations between the risk of EP and IVF-ET
among women with non-tubal infertility (AOR = 2.52,
95 % CI: 0.14–44.67). The risk of EP among women
using Chinese herbs and other ARTs remained the same
as that before stratification.
Table 1 Socio-demographic characteristics of all enrolled participants
EP IUP OR [95 % CI] p value
na (%) na (%)
Age (year)
≤20 24 (1.00) 32 (1.33) Reference 0.16
20–24 363 (15.06) 398 (16.47) 1.22 [0.70, 2.10]
25–29 753 (31.23) 772 (31.95) 1.30 [0.76, 2.23]
30–34 793 (32.89) 755 (31.25) 1.40 [0.82, 2.40]
35–39 332 (13.77) 322 (13.33) 1.38 [0.79, 2.39]
≥40 146 (6.06) 137 (5.67) 1.42 [0.80, 2.53]
Marital status
Married 2067 (85.80) 2088 (86.42) Reference 0.56
Unmarried 342 (14.20) 328 (13.58) 0.92 [0.78, 1.08]
Birth place
Shanghai 698 (28.95) 775 (32.08) Reference <10−3
Outside of Shanghai 1713 (71.05) 1641 (67.92) 1.16 [1.03, 1.31]
Education attainment
Collage or above 1061 (44.01) 1378 (57.04) Reference <10−3
High school 314 (13.02) 280 (11.59) 1.46 [1.22, 1.74]
Middle school 178 (7.38) 195 (8.07) 1.19 [0.95, 1.48]
Primary school or lower 858 (35.59) 563 (23.30) 1.98 [1.73, 2.26]
Occupation
Employed 1682 (69.88) 1897 (78.58) Reference <10−3
Self-employed 262 (10.89) 184 (7.62) 1.61 [1.32, 1.96]
Unemployed 463 (19.24) 333 (13.80) 1.57 [1.34, 1.83]
Personal annual income (RMB)
<50,000 1165 (48.32) 1093 (45.24) Reference 0.13
50,000-100,000 777 (32.23) 841 (34.81) 0.87 [0.76, 0.99]
> 100,000 469 (19.45) 482 (19.95) 0.91 [0.79, 1.06]
Smokingb
None smoker 2298 (95.31) 2294 (96.18) Reference 0.41
Occasional smoker 63 (2.61) 57 (2.39) 1.10 [0.77, 1.59]
Regular smoker 50 (2.07) 34 (1.43) 1.47 [0.95, 2.28]
Institutionsc
1 1404 (58.23) 1409 (58.32) Reference 1.00
2 276 (11.45) 274 (11.34) 1.01 [0.84, 1.21]
3 291 (12.07) 293 (12.13) 1.00 [0.83, 1.19]
4 272 (11.28) 272 (11.26) 1.00 [0.84, 1.21]
5 168 (6.97) 168 (6.95) 1.00 [0.80, 1.26]
EP ectopic pregnancy, IUP intrauterine pregnancy, OR odds ratio, CI confidence interval
aThe sum does not necessarily equal the sample size for all variables because of missing data
bOccasional smoker: cigarette smoking more than 4 times a week, but a day on average less than 1 cigarette. Regular smoker: cigarette smoking more than
1 cigarettes per day, continuous or accumulated 6 months
cCenter 1 = International Peace Maternity and Child Health Hospital; Center 2 = Shanghai First People's Hospital; Center 3 = Songjiang Central Hospital;
Center 4 = Songjiang Maternity and Child Health Hospital; Center 5 = Minhang Central Hospital
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Here, IVF-ET and current IUD use were found to be
high-risk factors associated with the incidence of EP inChina. It has been suggested that tubal factor infertility
rather than IVF-ET contributes to EP risk in women
who undergo IVE-ET. Furthermore, other traditional
Table 2 History of reproduction, gynecology, and surgery of all enrolled participates
EP IUP OR [95 % CI] p value
na (%) na (%)
Reproductive history
Number of previous abortions
0 873 (36.88) 930 (38.49) Reference 0.71
1 763 (32.23) 756 (31.29) 1.08 [0.94, 1.23]
2 485 (20.49) 497 (20.57) 1.04 [0.89, 1.21]
≥ 3 246 (10.39) 233 (9.64) 1.13 [0.92, 1.38]
Parity
0 1143 (48.29) 1280 (52.98) Reference <10−3
1 994 (41.99) 973 (40.27) 1.14 [1.02, 1.30]
≥ 2 230 (9.72) 163 (6.75) 1.58 [1.27, 1.96]
Gynecologic history
Previous EP
No 2093 (86.81) 2363 (97.81) Reference <10−3
Yes 318 (13.19) 53 (2.19) 6.77 [5.04, 9.11]
Serum Chlamydia trachomatis IgG test
Negative 1648 (69.13) 2099 (89.55) Reference <10−3
Positive 736 (30.87) 245 (10.45) 3.83 [3.27, 4.48]
Previous infertility
No 2005 (83.26) 2286 (95.65) Reference <10−3
Yes 403 (16.74) 104 (4.35) 4.42 [3.53, 5.53]
Categories of infertility
No 2005 (83.26) 2286 (95.65) Reference <10−3
Tubal infertility 326 (13.54) 73 (3.05) 5.09 [3.92, 6.61]
Non-tubal infertility 77 (3.20) 31 (1.30) 2.83 [1.86, 4.32]
ARTs applied in the current cycle of conceptionb
Spontaneous pregnancy 278 (68.98) 72 (69.23) Reference <10−3
IVF-ET 58 (14.39) 3 (2.88) 5.01 [1.53, 16.44]
Other ARTsc 46 (11.41) 18 (17.31) 0.66 [0.36, 1.21]
Chinese herb 21 (5.21) 11 (10.58) 0.49 [0.23, 1.07]
Surgical history
Previous cesarean sectiond
No 691 (56.09) 624 (54.74) Reference 0.79
Yes 541 (43.91) 516 (45.26) 0.95 [0.81, 1.11]
Previous adnexal surgery
No 1985 (82.33) 2322 (96.19) Reference <10−3
Yes 426 (17.67) 92 (3.81) 5.42 [4.29, 6.84]
Specific adnexal surgerye
Ovarian surgery 64 (15.02) 36 (39.13) 2.08 [1.38, 3.14] <10−3
Surgery for EP 237 (55.62) 38 (41.30) 7.30 [5.15, 10.33]
Tubal reconstructive surgery 90 (21.13) 14 (15.22) 7.52 [4.27, 13.25]
Female sterilization 21 (4.93) 2 (2.17) 12.28 [2.88, 52.45]
Reversal of tubal sterilization 14 (3.29) 2 (2.17) 8.19 [1.86, 36.07]
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Table 2 History of reproduction, gynecology, and surgery of all enrolled participates (Continued)
Previous appendectomy
No 2303 (95.84) 2346 (97.47) Reference 0.01
Yes 100 (4.16) 61 (2.53) 1.67 [1.21, 2.31]
EP ectopic pregnancy, IUP intrauterine pregnancy, OR odds ratio, CI confidence interval, ART assisted reproduction technology, IVF-ET in vitro fertilization and
embryo transfer
aThe sum does not necessarily equal the sample size for all variables because of missing data
bThe number of women with history of infertile was used as the denomintor to calculate the percentage
cOther ARTs includes ovarian stimulation, intrauterine insemination, luteal phase support and combination of ovarian stimulation and luteal phase support
dThe number of women having delivered a child was used as the denomintor to calculate the percentage
eThe number of women experienced adnexal surgeries was used as the denomintor to calculate the percentage
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incidence of EP.
The traditional risk factors for EP such as history of
previous EP, previous adnexal surgery, previous append-
ectomy and CT infection have been well described else-
where [1, 3, 6, 10]. It is not surprising that the results of
the current study are identical to previous reports of
increased subsequent risk of EP by these traditional risk
factors. This finding indicated that traditional risk fac-
tors still played a major role in the occurrence of EP.
Contraceptive failure is considered to be an important
factor associated with the increased incidence of EP [18].Table 3 Previous and current use of contraception
EP
na (%)



















Female sterilizationc 21 (0.88)
EP ectopic pregnancy, IUP intrauterine pregnancy, OR odds ratio, CI confidence inte
OCPs oral contraceptive pills
aThe sum does not necessarily equal the sample size for all variables because of mi
bOther contraceptive methods includes condom, rhythm method, withdrawal
cWomen who received reversal of tubal sterilization (n = 16) are not included hereDue to the national family planning policy, there may be
a difference in the contraception preferences in China
[19]. All methods of contraception can effectively reduce
the number of intrauterine and ectopic pregnancies.
However, from our findings, when pregnancies occur as
a result of contraceptive failure, the risk of ectopic preg-
nancy is significantly increased in women who become
pregnant after tubal sterilization or after using IUDs,
OCPs and LNG-EC. This finding from the present study
was identical to the results from a meta-analysis [20].
Previous studies indicated that progesterone and its
analogue, LNG, could effectively inhibit human tubalIUP OR [95 % CI] p value
na (%)
1311 (54.74) Reference 0.53
1084 (45.26) 1.05 [0.94, 1.17]
2106 (88.27) Reference <10−3
280 (11.74) 1.48 [1.25, 1.74]
2295 (95.55) Reference 0.06
107 (4.45) 1.25 [0.97, 1.63]
421 (17.50) Reference <10−3
1985 (82.50) 0.39 [0.34, 0.45]
1585 (65.60) Reference <10−3
653 (27.03) 0.81 [0.71, 0.93]
7 (0.29) 2.71 [1.11, 6.61]
145 (6.00) 2.79 [2.27, 3.43]
24 (0.99) 11.41 [7.45, 17.48]
2 (0.08) 12.45 [2.91, 53.18]
rval, IUDs intrauterine devices, LNG-EC levonorgestrel emergency contraception,
ssing data
Table 4 Multivariable logistic regression analysis predicting risk
factors for ectopic pregnancy
AOR [95 % CI] p value
Education attainment
Collage or above Reference <10−3
High school 1.21 [0.97, 1.50]
Middle school 0.96 [0.74, 1.24]
Primary school or lower 1.47 [1.23, 1.75]
Occupation
Employed Reference <10−2
Self-employed 1.30 [1.02, 1.66]
Unemployed 1.33 [1.10, 1.62]
Previous ectopic pregnancy
No Reference <10−3
Yes 2.72 [1.83, 4.05]
Serum Chlamydia trachomatis IgG test
Negative Reference <10−3
Positive 3.18 [2.64, 3.84]
Previous infertility
No Reference <10−3
Yes 2.18 [1.66, 2.88]
ART applied in the current cycle of conception
Spontaneous pregnancy Reference <10−3
IVF-ET 9.28 [2.14, 40.38]
Other ARTsa 0.80 [0.34, 1.88]
Chinese herb 0.80 [0.41, 1.56]
Previous adnexal surgery
No Reference <10−3
Yes 2.09 [1.49, 2.93]
Previous appendectomy
No Reference 0.01
Yes 1.64 [1.13, 2.37]
Previous use of IUDs
No Reference <10−3
Yes 1.72 [1.39, 2.13]
Previous use of other contraceptive
methodsb
No Reference <10−3
Yes 0.56 [0.47, 0.66]
Current contraceptive methods
No Reference <10−3
Other contraceptive methodsb 1.22 [0.99, 1.44]
OCPs 3.02 [1.16, 7.86]
Table 4 Multivariable logistic regression analysis predicting risk
factors for ectopic pregnancy (Continued)
LNG-EC 4.75 [3.79, 5.96]
IUDs 16.43 [10.42, 25.89]
Female sterilization 4.73 [1.04, 21.52]
AOR adjusted odds ratio, CI confident interval, ART assisted reproduction
technology, IVF-ET in vitro fertilization and embryo transfer, IUDs intrauterine
devices, LNG-EC levonorgestrel emergency contraception, OCPs oral
contraceptive pills
aOther ARTs includes ovarian stimulation, intrauterine insemination, luteal phase
support and combination of ovarian stimulation and luteal phase support
bOther contraceptive methods includes condom, rhythm method, withdrawal
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main cause of impaired embryo-tubal retention and
implantation [23]. Although we failed to obtain the in-
formation on the type of OCPs, women following OCPs
failure still should be aware of the possibilities of EP.
The results of this study were consistent with those of
previous studies, which showed that a history of infertil-
ity was a risk factor for EP [7, 9, 24]. It has been ac-
knowledged that IVF-ET is a valuable treatment for
infertility, especially for the treatment of tubal infertility.
Ever since the first pregnancy conceived following IVF-
ET treatment in 1976 was an ectopic one [25], the asso-
ciation between EP risk and ARTs has been debated
[26]. The incidence of EP following ARTs, especially
IVF-ET, has been reported to reduce since 2001 [27].
However, another study investigated the incidence of EP
in 128,314 pregnancies following ARTs according to the
presence or absence of tubal infertility, and concluded
that the incidence of EP following ARTs was higher in
women with tubal infertility than in women without
tubal infertility [28]. In addition, Strandell et al. sug-
gested that tubal infertility was the most prominent risk
factor for EP following IVF-ET [29]. However, our previ-
ous study failed to explore whether ART have an influ-
ence on the risk of EP, due to the small number of
women with non-tubal infertility becoming pregnant
with ARTs [16]. Based on this large multi-center study,
the stratification analysis indicated that women with
tubal infertility and not those with non-tubal infertility
were at a greater risk of EP when they underwent
IVF-ET in their current conception cycle. Therefore,
the present study indicated that it was IVF-ET that
contributed to the risk of EP for women who under-
went IVF-ET.
The present study has some limitations. Data collection
in this study was based on patients’ self-evaluation; hence,
we were unable to obtain additional information on the
types of OCPs, sterilization methods and IUDs for further
study. In addition, a limited number of women with non-
tubal infertility underwent IVF-ET to become pregnant;
thus, further prospective cohort studies are needed to
verify our findings on the association between EP and
Table 5 The association between EP and the mode of current pregnancy among women with tubal infertility or non-tubal infertility
Tubal infertilitya Non-tubal infertilityb
EP IUP AOR [95 % CI]d EP IUP AOR [95 % CI]d
nc (%) nc (%) nc (%) nc (%)
ARTs applied in the current cycle of conception
Spontaneous pregnancy 223 (68.41) 50 (68.49) Reference 55 (71.43) 22 (70.97) Reference
IVF-ET 55 (16.87) 2 (2.74) 8.99 [1.98, 40.84] 3 (3.90) 1 (3.23) 2.52 [0.14, 44.67]
Other ARTse 29 (8.9) 12 (16.44) 0.59 [0.25, 1.39] 17 (22.08) 6 (19.36) 0.94 [0.22, 3.98]
Chinese herb 19 (5.83) 9 (12.33) 0.78 [0.31, 2.01] 2 (2.60) 2 (6.45) 0.35 [0.03, 4.50]
EP ectopic pregnancy, IUP intrauterine pregnancy, AOR adjusted odds ratio, CI confident interval, IVF-ET in vitro fertilization and embryo transfer, ART assisted
reproduction technology
aThis analysis was restricted to 399 people with tubal infertility
bThis analysis was restricted to 108 people with non-tubal infertility
cThe sum does not necessarily equal the sample size for all variables because of missing data
dOdds ratios were adjusted for age, institutions, education attainment, occupation, previous EP, serum CT IgG test, previous adnexal surgery, previous
appendectomy, previous use of IUDs, previous use of other contraceptive methods and current contraceptive methods
eOther ARTs includes Ovarian stimulation, intrauterine insemination, luteal phase support and combination of ovarian stimulation and luteal phase support
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over, our data did not cover the technical and qualitative
aspects of the IVF procedure (e.g., the stimulation proto-
cols, endometrial and ovarian responses, embryo quality,
transfer technique, number of embryos transferred and
use of luteal support). Together, all these aspects may
contribute to the risk of EP in women with IVF-ET [29].
As a hospital-based case-control study, recall and selec-
tion bias must be acknowledged. The multi-centered de-
sign carried out across five hospitals covering the urban
and rural areas of Shanghai and the large sample size are
the strengths of this study, and helped recruit a relatively
good representation of the population thereby minimizing
selection bias.Conclusion
In this large multi-center case-control study, the risk of
EP still show correlation with some traditional risk factors
including previous EP, previous CT infection, previous
infertility, previous adnexal surgery, previous use of IUDs
and current use of IUDs, OCPs, LNG-EC and female
sterilization. Although IVF-ET has been associated with
an increased risk of EP incidence among women with
a history of infertility, this was only observed among
women with tubal infertility and not in women with
non-tubal infertility. In general, physicians should pay
attention to suspected EP cases with exposure to some
traditional risk factors. Furthermore, attention of EP
should also be paid to pregnant women following IVF-ET,
particularly among tubal infertility cases.Abbreviations
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